Last reviewed · How we verify

NCT05644652

Effect of Nordic Walking on Gait-asymmetry Patterns in Children With Hemiparesis

Completed NA Last updated 31 March 2026
What this trial tests

NA trial testing designed physical therapy program in Cerebral Palsy in 40 participants. Completed in 30 June 2024.

Timeline
1 July 2023
Primary endpoint
30 May 2024
30 June 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 July 2023
Primary completion30 May 2024
Estimated completion30 June 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 6 to 10, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nordic walking is a physical activity consisting of walking with poles similar to ski poles. The poles are designed for the purpose of activating the upper body during walking. The poles are equipped with rubber or spike tips and the walking itself resembles.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of Nordic Walking Versus Conventional Gait Training on Gait Asymmetry Patterns in Children With Hemiparesis.
    Nashed MA, Elnegmy EH, El-Tohamy AM, Abd-Elmonem AM. · · 2026 · PMID 41346090 · DOI 10.1002/pri.70139

Verify or expand the search:

Other trials of designed physical therapy program

Trials testing the same drug.

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05644652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing